3 ms·
This is a potentially dangerous direction to be taking the approval process in, though. It’s not meant to be for experimental treatments with at best inconclusi
by jolux 5y ago
This is a potentially dangerous direction to be taking the approval process in, though. It’s not meant to be for experimental treatments with at best inconclusive efficacy. Being an approved treatment is supposed to mean that an agent is efficacious against a disease.
- dragonwriter 5y ago“Efficacious”, though shouldn't be viewed as a binary, but as a sliding scale where the cutoff for any particular application depends on the balance of risks, available alternative treatments, etc.
- jolux 5y agoWhy shouldn’t it be viewed as a binary? They couldn’t find any evidence it was effective! You can’t get much more of a zero than that. Out of eleven, ten members of the advisory board were against approval and one was uncertain. I’ve got no idea why this drug was approved, unless it was an emotional appeal to the plight of Alzheimer’s patients, which should not guide which treatments we use.